Search Results - "Fields, Larry E"

Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 by Cutler, Jeffrey A, Sorlie, Paul D, Wolz, Michael, Thom, Thomas, Fields, Larry E, Roccella, Edward J

“…This study assesses trends in hypertension prevalence, blood pressure distributions and mean levels, and hypertension awareness, treatment, and control among…”
Get full text

Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke by Alberts, Mark J, Peacock, W. Frank, Fields, Larry E, Bunz, Thomas J, Nguyen, Elaine, Milentijevic, Dejan, Schein, Jeff R, Coleman, Craig I

Get full text

Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation by Nelson, Winnie W., PharmD, MS, MBA, Choi, Jiyoon C., PharmD, Vanderpoel, Julie, PharmD, MPA, Damaraju, Chandrasekharra V., PhD, Wildgoose, Peter, PhD, Fields, Larry E., MD, MBA, Schein, Jeffrey R., DrPh, MPH

“…This study determined the association between co-morbidities, including heart failure (HF) and time in therapeutic range (TTR), in patients with nonvalvular…”
Get full text

Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube by Moore, Kenneth T., Krook, Mark A., Vaidyanathan, Seema, Sarich, Troy C., Damaraju, C. V., Fields, Larry E.

“…Purpose Because some patients have difficulty swallowing a whole tablet, we investigated the relative bioavailability of a crushed 20 mg rivaroxaban tablet and…”
Get full text

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban by Tamayo, Sally, Frank Peacock, W., Patel, Manesh, Sicignano, Nicholas, Hopf, Kathleen P., Fields, Larry E., Sarich, Troy, Wu, Shujian, Yannicelli, Daniel, Yuan, Zhong

“…ABSTRACT Background In nonvalvular atrial fibrillation (NVAF), rivaroxaban is used to prevent stroke and systemic embolism. Objective To evaluate major…”
Get full text

The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide by Fields, Larry E, Burt, Vicki L, Cutler, Jeffery A, Hughes, Jeffrey, Roccella, Edward J, Sorlie, Paul

“…This study aims to estimate the absolute number of persons with hypertension (the hypertension burden) and time trends using data from the National Health and…”
Get full text

Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials by Nguyen, Elaine, White, C. Michael, Patel, Manesh R., Fields, Larry E., Peacock, W. Frank, Crivera, Concetta, Coleman, Craig I.

“…Using an I.M.S. LifeLink dataset (19 September 2014-11 September 2015), we compared U.S. cardiologist prescribing of the reduced dose of apixaban (2.5 mg) or…”
Get full text

Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice by Nakayama, Kei-ichi, Nakayama, Keiko, Negishi, Izumi, Kuida, Keisuke, Shinkai, Yoichi, Louie, Marjorie C., Fields, Larry E., Lucas, Phillip J., Stewart, Valerie, Alt, Frederick W., Loh, Dennis Y.

“…The bcl-2 proto-oncogene can prevent the death of many cell types. Mice were generated that were chimeric for the homozygous inactivation of bcl-2. Lymphocytes…”
Get full text

Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population by Mahan, Charles E, Fisher, Maxine D, Mills, Roger M, Fields, Larry E, Stephenson, Judith J, Fu, An-Chen, Spyropoulos, Alex C

“…Abstract Introduction Medically ill, hospitalized patients are at increased risk for venous thromboembolism (VTE) after discharge. This study aimed to examine…”
Get full text

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation by Nelson, Winnie W., Desai, Sunita, Damaraju, Chandrasekharrao V., Lu, Lang, Fields, Larry E., Wildgoose, Peter, Schein, Jeffery R.

“…Background Maintaining stable levels of anticoagulation using warfarin therapy is challenging. Few studies have examined the stability of the international…”
Get full text

International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation by Nelson, Winnie W., Desai, Sunita, Damaraju, C.V., Lu, Lang, Fields, Larry E., Wildgoose, Peter, Schein, Jeff R.

“…Abstract Background: Warfarin is effective for stroke prevention in patients with atrial fibrillation (AF), but international normalized ratio (INR) levels…”
Get full text

All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients by Mahan, Charles E, Fields, Larry E, Mills, Roger M, Stephenson, Judith J, Fu, An-Chen, Fisher, Maxine D, Spyropoulos, Alex C

“…Conflicting evidence exists regarding predictors of and antithrombotic benefit on mortality in hospitalised acutely-ill medical patients. We compared mortality…”
Get more information

Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation by Naccarelli, Gerald V., Cappato, Riccardo, Hohnloser, Stefan H., Marchlinski, Francis E., Wilber, David J., Xiang, Jim, Ma, Changsheng, Hess, Susanne, Davies, David Wyn, Fields, Larry E., Natale, Andrea

“…Purpose To evaluate the safety of uninterrupted rivaroxaban, a novel oral anticoagulant that directly inhibits factor Xa, and a vitamin K antagonist (VKA) in…”
Get full text

Mortality From Stroke and Ischemic Heart Disease Increases Exponentially With Blood Pressure by Fields, Larry E

Get full text

Antithrombotic medication use and bleeding risk in medically ill patients after hospitalization by Mahan, Charles E, Spyropoulos, Alex C, Fisher, Maxine D, Fields, Larry E, Mills, Roger M, Stephenson, Judith J, Fu, An-Chen, Klaskala, Winslow

“…Hospitalized medically ill patients receiving antithrombotic medications experience increased risk of bleeding. We examined antithrombotic use, bleeding rates,…”
Get more information

Absolute stroke mortality burden for non-Hispanic non-Latino whites was disproportionately higher than expected simply based on the US population in 2001 by Fields, Larry E

“…The absolute burden of stroke is a major determinant of health care costs and should also be considered when developing and implementing effective health…”
Get full text

Dysregulated Myelopoiesis in Mice Lacking Jak3 by Grossman, William J., Verbsky, James W., Yang, Liping, Berg, Leslie J., Fields, Larry E., Chaplin, David D., Ratner, Lee

“…Jak3 is a cytoplasmic tyrosine kinase that associates with the common chain of the interleukin-2 (IL-2) receptor and is involved in the function of the…”
Get full text

Expression of Janus Kinase 3 in Human Endothelial and Other Non-lymphoid and Non-myeloid Cells by Verbsky, J W, Bach, E A, Fang, Y F, Yang, L, Randolph, D A, Fields, L E

“…Members of the Janus kinase (Jak) family of protein tyrosine kinases have recently been implicated in the proximal signal transduction events of cytokine…”
Get full text

Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer by Azuma, T, Motoyama, N, Fields, L E, Loh, D Y

“…Transgenic mice containing the chloramphenicol acetyl transferase (CAT) gene driven by the immunoglobulin (Ig) VH promoter and the heavy chain intron enhancer…”
Get more information

Organ Injury Associated with Extrathymic Induction of Immune Tolerance in Doubly Transgenic Mice by Fields, Larry E., Loh, Dennis Y.

“…The developmental fate of autoreactive T cells encountering extrathymically expressed self-antigen was studied in a doubly transgenic mouse model system where…”
Get full text